Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24 Clinical Trial Not Allowed)

The Metabolic Dysregulation and Cancer Risk Program is focused on metabolic dysregulation as the key process linking obesity with cancer risk. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) will support a Coordinating Center to facilitate coordination across multiple individual research project grants. The overarching goal of the Metabolic Dysregulation and Cancer Risk Program is to enhance our knowledge of the dynamics, and underlying mechanisms, that link obesity, metabolic dysregulation, and increased cancer risk. The Coordinating Center will have several responsibilities, including, but not limited to, provide administrative support to the Metabolic Dysregulation and Cancer Risk Program, facilitate and participating in collaborative research, create standard operating procedures and best practices to identify common measures/targets, collect core common data elements and biological samples (when appropriate), facilitate communication across researchers, provide meeting support, coordinating reviews of applications and distribution of research funds, create and maintain the Program website, and facilitate deposition of data to NIH repositories (when appropriate). This FOA is published in parallel with RFA-CA-21-021 Research Project Grants for the Metabolic Dysregulation and Cancer Risk Program: a Transdisciplinary Approach to Obesity-associated Research (U01 Clinical Trial Optional). The Coordinating Center and the individual research grants funded under these FOAs together will constitute the Metabolic Dysregulation and Cancer Risk Program.